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Abstract
Impaired interactions between Calcineurin (Cn) and (Cu/Zn) superoxide dismutase (SOD1) are suspected to be responsible
for the formation of hyperphosphorylated protein aggregation in amyotrophic lateral sclerosis (ALS). Serine (Ser)- enriched
phosphorylated TDP-43 protein aggregation appears in the spinal cord of ALS animal models, and may be linked to the
reduced phosphatase activity of Cn. The mutant overexpressed S
 OD1G93A protein does not properly bind zinc (Zn) in animal
G93A
models; hence, mutant SOD1
–Cn interaction weakens. Consequently, unstable Cn fails to dephosphorylate TDP-43
that yields hyperphosphorylated TDP-43 aggregates. Our previous studies had suggested that Cn and SOD1 interaction was
necessary to keep Cn enzyme functional. We have observed low Cn level, increased Zn concentrations, and increased TDP43 protein levels in cervical, thoracic, lumbar, and sacral regions of the spinal cord tissue homogenates. This study further
supports our previously published work indicating that Cn stability depends on functional Cn–SOD1 interaction because
Zn is crucial for maintaining the Cn stability. Less active Cn did not efficiently dephosphorylate TDP-43; hence TDP-43
aggregations appeared in the spinal cord tissue.
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Amyotrophic lateral sclerosis (ALS) (a.k.a. Lou Gehrig
Disease) is a non-treatable progressive neurodegenerative
disease that is 100% fatal and claims about 30,000 lives per
year in the USA (http://www.als.org). Nearly 90% of these
cases are sporadic. The disease is characterized by the selective loss of motor neurons in the spinal cord, brain stem,
and cerebral (motor) cortex [1]. The causative factors of the
disease remain contentious at a molecular level, although
the hallmark of ALS is the formation of superoxide dismutase-enriched plaques in Lewy bodies in the spinal cord
[2]. Involvement of a previously discovered protein TDP-43
in ALS pathogenesis [3, 4] has recently attracted attention,
resulting in several important papers published during the
last decade [5–10]. Trans activating response region DNA
binding protein (TDP-43)-enriched plaques are observed in
ALS, and TDP-43 mutation-induced aggregates are considered as a promoting factor in ALS pathology [11]. TDP43 phosphorylation and subsequent aggregation have been
found in motor neurons [12, 13], suggesting that TDP-43
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aggregation due to abnormal phosphorylation may also be
relevant to reduced activity of Cn in ALS, since phosphatase
Cn regulates the TDP-43 phosphorylation in both lower and
higher organisms [14].
Partial inactivation of Cn in both sporadic and familial
ALS patients as well as in an asymptomatic carrier of a
dominant SOD1 mutation may suggest the role of Cn in the
pathogenesis of ALS [15].Both Cn and SOD1 are zinc (Zn)containing metalloproteins [16–21]. The failure of this protein–protein interaction(s) may lead to increased labile Zn
accumulation, thereby causing toxicity in motor neurons [22,
23]. Therefore, the involvement of Zn in the development
of ALS is another critical concept to be considered since
metal cations and oxidative injury have been implicated in
the pathogenesis of ALS [24, 25].
Elucidating these multiple factors will contribute to a
basic understanding of Cn/SOD1/TDP-43 protein interactions that may occur in the early stages of ALS development.
This could lead to early treatment options focused on restoring normal protein–protein interactions [26].
The focus of our work is to provide some preliminary
evidence that reduced Cn activity is due to weakened
interactions between SOD1 and Cn in the transgenic (Tg)
SOD1G93A rodent (i.e., rat and mouse) model. We hypothesize that poorly bound Zn in both metallo-enzymes (i.e.
SOD1 and Cn) dissociate and accumulate in the cytosol,
eventually inducing motor neuron death [27]. Subsequently,
the less functional Cn enzyme would fail to dephosphorylate
TDP-43, leading to the formation of hyperphosphorylated
TDP-43 aggregates that are considered to be the hallmark
of neuropathology in 90% of ALS cases [12].

Materials and Methods
Animals
Tg S OD1 G93A rat (B6.Cg-Tg(SOD1*G93A)1Gur/J)
breeders were obtained from Taconic and offspring were
genotyped using the protocol described in the Jackson
Laboratory website (https://www2.jax.org/protocolsdb/
f?p=116:5:0::NO:5:P5_MASTER_PROTOCOL_ID,P5_
JRS_CODE:9877,004435). Rats were fed normal chow
(Harlan Teklad rodent diet 8604 from Teklad diets, Madison, WI) and were housed in University of Kansas Medical
Center (KUMC) animal facilities for 6 months. Animal use
was approved by KUMC IACUC protocol (#2013-2142).

Tissues
After animals were deeply anesthetized and decapitated,
their spinal cords were flushed out according to a previously published method [28]. Briefly, the spinal column was
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sectioned at about the 4th sacral vertebra. A 20″–22″ gauge
needle attached to a 10 ml syringe was inserted into the
caudal opening of the spinal column. Approximately 5 ml
of PBS was gently injected to flush the spinal cord from the
rostral end of the severed spinal column. The cord was then
sectioned into cervical, thoracic, lumbar, and sacral regions
according to a template that served as a visual aid (Fig. S1).
The template was constructed based on anatomic atlas of the
rat spinal cord [29].

Homogenate
All glassware was washed with strong acids (i.e., nitric acid
and perchloric acid) to remove possible contamination for
trace elements [30] that may interfere fluorometric zinc
analysis. The spinal cord sections were weighed and placed
in a pre-chilled 1 ml glass homogenizer on ice. Ten volumes
of tissue homogenization buffer (0.32 M sucrose; 10 mM
HEPES; 0.5 mM MgSO4; 10 mM ε-amino caproic acid; pH
7.4) and the tissues (10 vol. buffer/g wet tissue) were gently homogenized on ice with 10–15 strokes (just enough to
completely dissociate the tissue) using the cooled pestle.
The protein concentrations were determined by the bicinchoninic acid (BCA) spectrophotometric method (Thermo
Scientific, Pierce™ BCA Protein Assay Kit; Cat#23227) and
the homogenate aliquots were stored at − 80 °C until use.

Western Blot Analysis
Spinal cord section homogenates were resolved in pre-cast
4–20% SDS/PAGE (Bio-Rad, mini-PROTEAN TGX™
gels; Cat#456–1095) under the reducing conditions. The
proteins were transferred onto a transfer membrane (Millipore, Immobilon® PVDF membrane, Cat#IPFL00010)
and probed with anti-Calcineurinα, (Cat#C1956; SigmaAldrich, St Louis, MO, USA; monoclonal antibody) antiCalcineurinβ, (Cat#C0581; Sigma-Aldrich, St Louis, MO,
USA; monoclonal antibody), anti-SOD1 (Cat#100269-1-AP;
Protein Tech, USA, Rabbit polyclonal antibody), and antiTDP-43 (Cat#10782-2-AP; Protein Tech, USA) antibodies.
Odyssey/LI-COR detection system (LI-COR Biosciences,
Nebraska, USA) was used for analyzing the protein bands
(Image Studio Ver.3.1).

Zinc Analysis
Spinal cord tissue homogenates were centrifuged (16 K×g;
30 min at 4 °C) in order to obtain a clear supernatant. Protein
concentrations were measured by BCA assay. The supernatant samples were prepared for Zn assay analysis and the
concentrations were measured by a fluorometric Zinc quantification kit (Abcam Inc., USA; Cat#ab176725) according to the manufacturer’s provided protocol. A Bio-Tek
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microplate reader (Model: Synergy HT, USA equipped with
Gen 5 software version 2.05.5) was used for the fluorescence
measurement.

Statistical Analysis
Mann–Whitney U rank sum tests followed by the calculation of two-tailed p values were used for determining the
significance between groups. SigmaPlot (ver.12.5) was used
for graphing and statistical analysis.

Results
Calcineurin Protein Levels Were Lower in Tg Cervical
and Thoracic Regions of the Spinal Cord
We analyzed protein levels of both the catalytic subunit of
Calcineurin (CnA or PPP3CA) and the regulatory subunit
(CnB or PPP3R1). We observed significantly lower catalytic
subunit protein levels in the cervical (P ≤ 0.001) and thoracic
(P ≤ 0.008) spinal cord of Tg animals, but not in the lumbar
region (P ≤ 0.130) in (Fig. 1a). There were no differences in
the CnB-regulatory subunit protein levels between the two
groups (Fig. 1b). We were unable to harvest sufficient tissue from the sacral region to perform CnA and CnB western
blot analysis.

TDP‑43 Protein Levels in Spinal Cord Regions
We measured spinal cord TDP-43 protein levels by Western
blot analysis. We observed an increasing trends of TDP-43
in thoracic, lumbar, and sacral regions; however, no statistically significant differences in TDP-43 between Tg and WT
rats in any of the regions measured (Fig. 2).

Fig. 1  a Catalytic subunit CnA protein levels. Significantly lower catalytic subunit protein levels were observed in the cervical (P ≤ 0.001)
and thoracic (P ≤ 0.008) spinal cord of Tg animals, but not in the
lumbar region (P ≤ 0.130). Each bar represents the average of five
animals for each group (n = 5). Data are mean ± SEM. b Regulatory
subunit CnB protein levels. No differences were observed in the CnBregulatory subunit protein levels between the two groups. Data are
mean ± SEM (n = 5)

Predicted Phosphorylation Site Analysis for TDP‑43
We have employed a computer based Predictor of Natural
Disordered Region (PONDR®) algorithm using TDP-43
sequence (NCBI accession code: Q5R5W2.1). Disordered
Enhanced Phosphorylation Predictor (DEPP) analysis predicted 28 potential phosphorylation sites and a majority of
them were Ser amino acid enriched on the C-terminus (aa
369–410) (Fig. S5).

Higher Zn Concentrations Were Measured in Tg
Lumbar Spinal Cord
We measured the total Zn concentrations in all regions of rat
spinal cord (Fig. 3). We measured significantly greater Zn
in the lumbar region of Tg animals (P ≤ 0.01). The greater
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Fig. 2  TDP-43 protein levels in spinal cord regions of SOD1G93A
Tg rat. TDP-43 protein levels in spinal cord regions of WT (n = 6)
and Tg (n = 8) animals. Pan anti-TDP-43 Ab was used for Western
blot analysis. No statistically significant difference was observed in
cervical (P < 0.0663), in thoracic (P < 0.250), in lumbar (P < 0.393),
and in sacral (P < 0.157) regions of WT and Tg animals. Data are
mean ± SEM
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Fig. 3  Zinc concentrations in rat spinal cord regions. Significantly
greater Zn concentrations were measured in the lumbar region of
Tg animals (**P ≤ 0.01). The Zn levels in the cervical, thoracic,
and sacral regions did not reach statistical significance. Data are
mean ± SEM (n = 5)

Zn levels in the cervical, thoracic, and sacral regions did not
reach statistical significance.

Discussion
We previously showed that Cn activity depends on the presence of normal homodimer SOD1 in vitro and concluded
that Cn–SOD1 interactions actually protect SOD1 dimers
from oxidative modification [31]. Evidence provided in
the literature suggests that depletion of Zn likely leads the
SOD1 protein to undergo aggregation under oxidative conditions [32, 33] We have hypothesized that (1) the mutation
in SOD1G93A weakens Zn binding in SOD1 [34]; leading
the protein misfolding; (2) this abnormal SOD1 may not
efficiently interact with Cn, promoting Zn loss and reduced
activity in Cn [31]; (3) less active Cn fails to dephosphorylate TDP-43, leading TDP-43 hyperphosphorylation; (4)
failed SOD1–Cn interactions contributes to Zn accumulation. Data provided in this study are in agreement with this
hypothesis. We have observed reduced Cn protein amounts
in rat spinal cord samples as determined by Western blot
analysis (Fig. 1a, b). In unpublished data, we also observed
reduced Cn phosphatase activity levels in Tg SOD1G93A
mice (Fig. S2). We did not analyze Cn enzyme activity
levels in spinal cord homogenates in rat due to insufficient
amount of samples; however, we predict that low Cn levels
reflect low Cn ativity. We have tested both C
 nA (~61 kDa
calmodulin-binding catalytic subunit) and C
 nB (~19 kDa
Ca2+/calmodulin-binding regulatory subunit) protein levels in spinal cord regions and found that CnA protein level
was significantly lower in Tg SOD1G93A rat spinal cord
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Fig. 4  Proposed model for Cn–SOD1 impaired interaction that leads
for TDP-43 aggregation and Zn accumulation in ALS

regions as compare to WT (Fig. 1a). On the other hand,
CnB subunit levels did not differ between the two groups
(Fig. 1b). Although we observed a C
 nB upregulation pattern
in thoracic region of Tg animals, this increase did not reach
statistically significant level. CnB subunit is involved in the
apoptotic reaction cascade in neurodegeneration [34]. We
expected that CnB subunit upregulation would be observed
in the spinal cord tissue homogenates. Based on these
observations, we propose that Cn–SOD1 interaction fails
due to alterations in the SOD1G93A mutation, then the less
active Cn fails to dephosphorylate TDP-43; consequently,
hyperphosphorylated TDP-43 begins to aggregate (Fig. 4).
Because the impaired SOD1–Cn interaction is not stabilized,
Zn ions would be dissociated from both Cn and SOD1 and
form aggregates. The molar ratio between SOD1:Cn was
determined to be 2:1 in in vitro conditions for proper Cn
activity [31]. Even though T
 gSOD1G93A rat expresses more
SOD1 (Fig. S3), Cn levels remained low in thoracic and
lumbar spinal cord regions. Decreased Cn enzyme activity
in lymphocytes from ALS patients was also reported in the
literature [15].
Recent studies have suggested that Zn dyshomeostasis
occurs in spinal cords of SOD1G93A transgenic mice and may
contribute to motoneuron degeneration [35, 36]; however,
these studies do not specify the region(s) of the spinal cord
where Zn accumulation is prevalent. In this study, we found
that greater Zn concentration is present in the lumbar spinal
cord of SOD1G93A rats (Fig. 3) and mice (Fig. S4).
The labile Zn aggregation in neurons and astrocytes
in the spinal cord of S
 OD1G93A transgenic mice supports
the concept of the Zn dyshomeostasis in ALS [22]. Zinc
is an essential cofactor for enzymatic activity and 10% of
all mammalian proteins require Zn for proper folding [37].
Although Zn modulates the function of many other proteins,
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its homeostasis is poorly understood in health and in disease
conditions. The elevated toxic levels of trace element Zn
were reported in ALS patients reviewed by Smith and Lee
[38], suggesting the link between environmental causes and
an increased incidence of the disease. A possible approach
would be to study the metal binding properties of SOD1,
since SOD1 is a metalloprotein and binds to both Cu and
Zn. The G93A SOD1 mutation selectively destabilizes the
remote metal binding region (i.e., Zn and Cu binding region)
[39]. We have proposed a model (Fig. 4) where unstable
Zn-deficient SOD1 proteins may destabilize Cn that weakly
binds Zn [31], causing impaired SOD1–Cn interaction. Subsequently, destabilized Cn fails to dephosphorylate TDP-43,
leading to TDP-43 protein aggregation. However, this model
needs to be tested in cell-based studies. Alterations in the
metal-binding sites of another mutant S
 OD1G85R contributes
to toxicity in SOD1-linked ALS [40]. This observation further supports the notion that Zn deficiency may contribute
to the less stable SOD1 which enhances SOD1 aggregation
in neuronal cells. This hypothesis was recently challenged
by reports that SOD1 stabilization is not due to dimerization
and proper metallation but disulfide formation between two
SOD1 homodimer [40, 41]. In addition, liberated Zn may
create local metal toxicity. There are extensive reports identifying the neurotoxic effects of Zn, however the mechanism
remain unclear [42].
Calcineurin is a Ser/Thr specific phosphatase [16]. Ser
amino acid enriched C-terminus region of TDP-43 (Fig. S5)
is a potential substrate for Cn. Therefore, decreased activity
of Cn may impair the dephosphorylation of TDP-43; hence,
TDP-43 aggregations form in SOD1G93A Tg rat spinal cord
tissue (Fig. 2, Fig. S6).
In conclusion, the complex biology of ALS necessitates
the study of relevant biochemical events so that logical
connections among the biomolecules and metal ions can
be established. In this study, we have demonstrated that
impaired SOD1G93A–Cn interaction gave rise to three important consequences in vivo; (1) reduced Cn enzyme levels,
(2) labile Zn accumulation, and (3) TDP-43 aggregation.
These events would potentially have contributed to ALS
progression in the rat model. Further studies should design
effective small molecules that maintain Cn activity so that
hyperphosphorylated TDP-43 aggregation is controlled if
not stopped. Stabilized Cn would not contribute labile Zn
after dissociation from Cn molecule; therefore, Zn aggregation would be relatively less.
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